July 2017

LGC acquires LINK and strengthens its oligo reagents offering

LGC announced today that it has acquired LINK Technologies, a premier supplier of speciality reagents for oligonucleotide synthesis. LINK’s products are used by oligonucleotide synthesis companies, university and commercial research departments as well as contract manufacturing organisations in the biotech sector.

Following the acquisition, LGC will combine its Biosearch oligonucleotide reagent group, its Prime Synthesis CPG business and LINK into a newly-formed Nucleic Acid Chemistry business that will sit within its Genomics division and trade as LGC LINK.

Brian Kim, President and Managing Director, Genomics division, LGC, said, “We are delighted to be adding LINK products to our portfolio and their deep chemistry and commercial capabilities to our team. LINK’s products are a great complement to LGC’s, providing our customers with an expanded product range, increased supply chain security, improved global logistics and industry-leading customer support.”

Marc Lemaitre, Chairman of LINK said, "Over three decades, LINK has developed excellence in manufacturing a large portfolio of reagents for oligonucleotide synthesis, which are sold across the world. As a result, our products are found in many research, diagnostic and increasingly therapeutic oligonucleotides. Further to the acquisition, LINK will become an integral part of the LGC family and better placed to meet the challenges presented by the rapid development of the international markets for oligonucleotides. The new Nucleic Acid Chemistry business, incorporating the LINK, Biosearch and Prime-Synthesis portfolios, will be a tremendous one-stop-shop for a large array of customers. LGC’s offering and international reach fit perfectly with LINK’s manufacturing and customer support capabilities.  We expect rapid growth of the combined group.”

LINK is certified to ISO9001:2015 and has 21 employees based at Bellshill, near Glasgow. LGC will continue to operate from LINK’s Bellshill facility and will continue to supply its products.

The company was founded in 1989, and first operated from laboratories within Glasgow University.